Krystal Biotech Inc (KRYS) support and resistance · P/E 46, rev $290.5M
Krystal Biotech Inc (KRYS) is a biotechnology company listed on NASDAQ.
This page maps Krystal Biotech Inc (KRYS) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported KRYS revenue for 2024-12-31 was $290.5M. Net income was $89.2M. Revenue was up 473.0% from 2023-12-31 to 2024-12-31. KRYS currently screens at market cap $10.17B and trailing P/E 46.1.
KRYS currently screens at market cap $10.17B and trailing P/E 46.1. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new KRYS 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the KRYS quote page for the session range and the stock page for the full model.
Not investment advice.